The Cochrane US Network recently held a landmark hybrid meeting, bringing together members both physically and virtually. Hosted by the American College of Physicians (ACP) in Philadelphia, the event marked the first in-person gathering dedicated to the US Network in five years.

The ACP, a founding member and the sole medical organization with this distinction within the US Network, played a key role in the meeting's leadership. Dr. Amir Qaseem, ACP's Chief Science Officer, spearheaded the event, which also welcomed the participation of Karla Soares-Weiser, Editor in Chief of Cochrane.

This significant gathering focused on fostering collaboration and strategic direction for the US Network. Invited speakers addressed critical topics in healthcare, including the evolving role of Artificial Intelligence (AI), achieving health equity, and best practices in research publications.

The meeting served as a vital platform for knowledge exchange and networking among members. Discussions centered on the US Network's priorities for the coming year, with a particular emphasis on raising awareness of Cochrane's contributions to evidence-based medicine in the United States. Strategic dissemination of Cochrane's research findings and advocacy for healthcare based on sound evidence were also highlighted areas of focus.

This hybrid meeting signifies a renewed commitment to strengthening the Cochrane US Network's impact on American healthcare. By harnessing the expertise of its members and fostering collaboration, the Network is well-positioned to play a vital role in advancing evidence-informed decision-making for patients and healthcare professionals alike.